Merck (MRK) Assets Average (2009 - 2026)

Merck has disclosed Assets Average across 18 years of filings, most recently posting $132.8 billion for Q1 2026.

• In Q1 2026, Assets Average rose 14.35% year-over-year to $132.8 billion; the TTM figure through Mar 2026 stood at $132.8 billion (up 14.35% YoY), while the FY2025 annual figure was $127.0 billion, up 13.49% from the prior year.
• Assets Average held at $132.8 billion in Q1 2026, from $133.2 billion in the prior quarter.
• Over the last five years, Assets Average for MRK reached as high as $133.2 billion in Q4 2025 and fell as low as $105.6 billion in Q3 2023.
• The 5-year median for Assets Average is $108.5 billion (2023), against an average of $113.2 billion.
• Annual changes were most pronounced in 2022 — Assets Average gained 17.75% — and 2024, when it decreased 2.04%.
• A 5-year view of Assets Average shows it stood at $108.1 billion in 2022, then slipped by 1.31% to $106.7 billion in 2023, then gained by 9.95% to $117.3 billion in 2024, then climbed by 13.54% to $133.2 billion in 2025, then declined by 0.32% to $132.8 billion in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $132.8 billion, $133.2 billion, and $123.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.